Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Total Voting Rights

30 Nov 2009 07:00

RNS Number : 2102D
Deltex Medical Group PLC
30 November 2009
 



Deltex Medical Group plc

Total Voting Rights and Capital 

Deltex Medical Group plc ("Deltex" or the "Company") confirms that at 30 November 2009 its issued share capital comprises 124,618,973 ordinary shares of 1p each in the Company ("Ordinary Shares"). All of the Ordinary Shares have equal voting rights, and none of the Ordinary Shares are held in Treasury. The total number of voting rights in Deltex is therefore 124,618,973.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Deltex under the Disclosure and Transparency Rules. 

For further information, please contact:-

Deltex Medical Group plc 01243 774 837Paul Mitchell, Finance Director/Company Secretary

Nominated Adviser and Broker 0207 398 1600

Arden Partners plc

Christopher Hardie

Matthew Armitt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRZGMZMZNGGLZM
Date   Source Headline
21st Feb 20257:00 amRNSCancellation - Deltex Medical Group Plc
12th Feb 20251:26 pmRNSResult of General Meeting
11th Feb 20256:09 pmRNSHolding in Company
11th Feb 20254:29 pmRNSHolding(s) in Company
10th Feb 20257:00 amRNSHolding in Company
5th Feb 202510:35 amRNSHolding(s) in Company
29th Jan 20253:07 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSProposed cancellation of trading on AIM
20th Jan 20254:28 pmRNSHolding(s) in Company
20th Jan 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSYear-end trading update and proposed cancellation
2nd Dec 20243:20 pmRNSHolding in Company
23rd Sep 20247:00 amRNSInterim results to 30 June 2024
11th Jul 202412:29 pmRNSHolding in Company
10th Jul 202411:46 amRNSHolding in Company
4th Jul 20247:00 amRNSHalf-year Trading Update
12th Jun 20247:00 amRNSNew share plans and grant of share options
4th Jun 20247:00 amRNSAward to NHS Supply Chain Framework Agreement
8th May 202412:50 pmRNSResult of Annual General Meeting
8th May 20247:00 amRNSChairman’s Statement to the Annual General Meeting
8th Apr 20245:03 pmRNSHolding(s) in Company
8th Apr 20247:00 amRNSPosting of Annual Report & Notice of AGM
28th Mar 20247:00 amRNSResults for the year ended 31 December 2023
2nd Feb 20245:11 pmRNSHolding(s) in Company
31st Jan 20245:00 pmRNSTotal Voting Rights
18th Jan 20245:01 pmRNSIssue of Equity
18th Jan 20247:00 amRNSYear-end trading update
4th Dec 20237:00 amRNSCommercial update, board changes & new auditor
18th Sep 20237:00 amRNSInterim results to 30 June 2023
31st Aug 20235:00 pmRNSTotal Voting Rights
2nd Aug 20236:23 pmRNSHolding(s) in Company
2nd Aug 20235:32 pmRNSHolding(s) in Company
2nd Aug 20238:00 amRNSFundraising completion, trading restoration & TVR
2nd Aug 20237:30 amRNSRestoration - Deltex Medical Group PLC
1st Aug 202310:04 amRNSResult of General Meeting
24th Jul 20237:00 amRNSResult of Retail Offer
18th Jul 20234:47 pmRNSExtension of Retail Offer Closing Time
14th Jul 20236:03 pmRNSRetail offer to raise up to £500,000
14th Jul 20236:01 pmRNSPlacing, Subscription and Retail Offer
10th Jul 20237:00 amRNSRelease of new next generation TrueVue System
6th Jul 20237:13 amRNSHalf-year Trading Update & Potential Fundraise
26th Jun 20237:30 amRNSSuspension - Deltex Medical Group PLC
26th Jun 20237:00 amRNSTrading update and suspension of trading on AIM
19th May 20231:35 pmRNSHolding(s) in Company
17th May 20233:24 pmRNSResult of AGM
17th May 20237:00 amRNSChairman’s Statement to the Annual General Meeting
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSNew monitor launch update & new loan facility
11th Apr 20235:43 pmRNSIssue of Equity
30th Mar 20237:00 amRNSResults for the year ended 31 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.